A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Clinical trial NCT03062579 · COMPLETED

Trial details

NCT number: NCT03062579
Sponsor: Fu-Dong Shi
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders Neuromyelitis Optica Devic's Disease

Start date: 2017-02-01
Primary completion: 2018-02-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.